[Research progress on prognostic prediction models for patients undergoing extracorporeal membrane oxygenation].

Extracorporeal membrane oxygenation (ECMO), as a critical life support technology, has played a significant role in treating patients with refractory respiratory and circulatory failure. In recent years, with the advancements in medical technology, the scope of application of ECMO has been expanding, especially in the fields of acute respiratory distress syndrome, cardiogenic shock and other important roles. However, its high costs, complex operation, and associated risks of complications remain challenges in clinical practice.

RASA4 inhibits the HIFα signaling pathway to suppress proliferation of cervical cancer cells.

RAS p21 protein activator 4 (RASA4) has been recognized as a Ca-promoted Ras-MAPK pathway suppressor that inhibits tumor growth. However, the role of RASA4 in cervical squamous cell carcinoma (CESC) remains unclear. The mRNA levels of RASA4 were analyzed using the GEO and GEPIA databases.